| Autor: |
Kobayashi-Sakamoto M; Department of Preventive Dentistry, Ohu University School of Dentistry, Koriyama, Fukushima 963-8611, Japan., Maeda T; Department of Oral Function and Molecular Biology, Ohu University School of Dentistry, Koriyama, Fukushima 963-8611, Japan., Kimura M; Department of Microbiology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Toyama 930-0194, Japan., Yusa J; Department of Oral Medical Science, Ohu University School of Dentistry, Koriyama, Fukushima 963-8611, Japan., Ito H; Department of Oral Medical Science, Ohu University School of Dentistry, Koriyama, Fukushima 963-8611, Japan., Tani H; Department of Virology, Toyama Institute of Health, Toyama, Toyama 939-0363, Japan., Kato Y; Department of Oral Function and Molecular Biology, Ohu University School of Dentistry, Koriyama, Fukushima 963-8611, Japan., Hirose K; Department of Preventive Dentistry, Ohu University School of Dentistry, Koriyama, Fukushima 963-8611, Japan. |
| Abstrakt: |
Bovine lactoferrin (bLF) is a naturally occurring glycoprotein with antibacterial and antiviral activities. We evaluated whether bLF can prevent viral infections in the human intestinal epithelial cell line Caco-2. To assess antiviral responses, we measured the levels of interferon (IFN) expression, IFN-stimulated gene expression, and infection with a pseudotyped virus bearing either severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein or vesicular stomatitis virus (VSV)-G protein after treatment of cells with both bLF and polyinosinic-polycytidylic acid, an analog of double-stranded RNA that mimics viral infection. Combination treatment of cells with both bLF and polyinosinic-polycytidylic acid increased mRNA and protein expression of several IFN genes ( IFNB, IFNL1 , and IFNL2 ) and IFN-stimulated genes ( ISG15, MX1, IFITM1 , and IFITM3 ) in Caco-2 cells. However, treatment with bLF alone did not induce an antiviral response. Furthermore, combination treatment suppressed infection of the SARS-CoV-2 pseudotyped virus more efficiently than did bLF treatment alone, even though combination treatment increased the expression of mRNA encoding ACE2. These results indicate that bLF increases the antiviral response associated with the double-stranded RNA-stimulated signaling pathway. Our results also suggest that bLF and double-stranded RNA analogs can be used to treat viral infections, including those caused by SARS-CoV-2. |
